Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network. With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.
Here, you can go directly to the respective years of Investor Relations News:
Frankfurt am Main, Germany, 04 July 2019 - creditshelf Aktiengesellschaft, a pioneer in digital SME financing in Germany, managed to more than double its arranged loan volume in the first half 2019 compared with the same period of the previous year. The positive development of its loan business in the first half 2019 is reflected in the following numbers:
02. Juli 2019 | Manz AG successfully holds 2019 Annual General Meeting
Manz AG, a global high-tech equipment manufacturer with a comprehensive technology portfolio, held its 2019 annual general meeting on Tuesday at the FILharmonie in Filderstadt. The presence of the represented share capital equaled approximately 60,35 %; all of the agenda items were adopted by a large majority.
The board used the opportunity to report the operational and strategic development of Manz AG for fiscal year 2018 to the shareholders in detail. The past year was characterized by clear advances in the sustainable increase of Manz AG’s competitiveness and profitability. Due to direct organizational and process improvements as well as the optimized product portfolio, sales as well as the result improved significantly compared to the previous year. In this context, the board thanked all of its employees for successful efforts over the past years.
01. Juli 2019 | Dermapharm Holding SE with increased free float
Grünwald, July 1, 2019 – Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded drugs for selected therapeutic areas in Germany with a growing international presence, has been informed by Themis Beteiligungs-Aktiengesellschaft ("Themis") that on June 28, 2019 580,000 shares of Dermapharm for the price of 30.00 Euros per share have been sold outside a trading venue.
27 June 2019 | DEAG to hold 2019 Annual General Meeting in Berlin
Berlin, 27 June 2019 – DEAG Deutsche Entertainment AG (DEAG), Berlin, listed in the Prime Standard, ISIN: DE000A0Z23G6, WKN: A0Z23G, ERMK, successfully held its 2019 Annual General Meeting today. Looking back on 40 years of company history and 20 years of stock market listing, the Executive Board informed the shareholders in detail about one of the most successful financial years in the company’s history.